-
By The Associated Press |
May 20, 2013
Drugstore chain Rite Aid Corp.'s board of directors has elected former Blue Shield of California Chairman and CEO Bruce G. Bodaken to its board of directors.
-
By Tom Murphy |
April 4, 2013
Walgreen Co. has stretched the reach of its drugstore clinics beyond treating ankle sprains and sinus infections to handling chronic diseases such as diabetes, asthma and high blood pressure.
-
By The Associated Press |
April 1, 2013
Drugstore operator CVS Caremark Corp.'s board of directors has elected former Johnson & Johnson Chairman and CEO William C. Weldon to join the board.
-
By The Associated Press |
March 1, 2013
Rite Aid is expanding a new drugstore clinic that allows customers to have virtual visits with doctors who can diagnose conditions and prescribe medications based on a 10-minute consultation.
-
By Tom Murphy |
February 6, 2013
CVS Caremark's fourth-quarter earnings climbed 6 percent, as new customers and Medicare prescription drug plans helped its pharmacy benefits management business, and revenue from the chain's established drugstores grew.
-
By Tom Murphy |
January 9, 2013
Flu season may have a more muted impact on some health care stocks than investors expect, even though experts warn that this year's version is shaping up to be more intense than recent seasons.
-
By Tom Murphy |
December 21, 2012
Walgreen Co.'s fiscal first-quarter earnings sank nearly 26 percent as the nation's largest drugstore chain filled fewer prescriptions and absorbed costs tied to acquisitions and Superstorm Sandy.
-
By Tom Murphy |
December 20, 2012
Walgreen Co. will report fiscal first-quarter earnings for fiscal 2013 on Friday, and analysts will be looking for more signs that the nation's largest drugstore chain is repairing its revenue after a temporary business split with Express Scripts Holding Co.
-
By Linda A. Johnson |
November 6, 2012
CVS Caremark Corp. said Tuesday that its third-quarter earnings climbed 16 percent. The drugstore operator and pharmacy benefits manager posted revenue increases in both businesses, benefiting from new customers won from rivals, and raised its full-year earnings outlook.
-
By Tom Murphy |
September 28, 2012
Walgreen Co.'s fiscal fourth quarter net income tumbled 55 percent compared to a year ago when the drugstore operator recorded a big business sale gain.